A detailed history of Ghost Tree Capital, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 140,000 shares of BPMC stock, worth $12.6 Million. This represents 4.85% of its overall portfolio holdings.

Number of Shares
140,000
Previous 40,000 250.0%
Holding current value
$12.6 Million
Previous $4.31 Million 200.26%
% of portfolio
4.85%
Previous 1.76%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$84.1 - $120.5 $8.41 Million - $12.1 Million
100,000 Added 250.0%
140,000 $12.9 Million
Q2 2024

Aug 14, 2024

SELL
$85.18 - $108.78 $2.79 Million - $3.56 Million
-32,761 Reduced 45.03%
40,000 $4.31 Million
Q1 2024

May 15, 2024

BUY
$73.17 - $99.79 $5.32 Million - $7.26 Million
72,761 New
72,761 $6.9 Million
Q4 2022

Feb 14, 2023

SELL
$41.06 - $66.48 $1.85 Million - $2.99 Million
-45,000 Reduced 69.23%
20,000 $876,000
Q3 2022

Nov 14, 2022

BUY
$49.93 - $77.7 $3.25 Million - $5.05 Million
65,000 New
65,000 $4.28 Million
Q1 2020

May 15, 2020

SELL
$48.11 - $82.22 $7.22 Million - $12.3 Million
-150,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$66.73 - $82.59 $11.7 Million - $14.5 Million
-175,000 Reduced 53.85%
150,000 $12 Million
Q3 2019

Nov 14, 2019

SELL
$72.9 - $101.41 $3.65 Million - $5.07 Million
-50,000 Reduced 13.33%
325,000 $23.9 Million
Q2 2019

Aug 14, 2019

BUY
$73.54 - $97.8 $9.93 Million - $13.2 Million
135,000 Added 56.25%
375,000 $35.4 Million
Q1 2019

May 15, 2019

BUY
$48.7 - $86.6 $11.7 Million - $20.8 Million
240,000 New
240,000 $19.2 Million
Q2 2018

Aug 14, 2018

SELL
$60.96 - $101.18 $7.32 Million - $12.1 Million
-120,000 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$73.28 - $102.95 $2.2 Million - $3.09 Million
-30,000 Reduced 20.0%
120,000 $11 Million
Q4 2017

Feb 14, 2018

BUY
$62.91 - $88.32 $9.44 Million - $13.2 Million
150,000
150,000 $11.3 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.38B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.